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IRAK-M Is a Negative Regulator
of Toll-like Receptor Signaling
receptor homology domain) and death domain (DD), and
binds to the intracellular TIR domain of TLRs (Medzhitov
et al., 1998; Wesche et al., 1997). Upon TLR stimulation,
Koichi Kobayashi,1 Lorraine D. Hernandez,2
Jorge E. Gala´n,2 Charles A. Janeway, Jr.,1
Ruslan Medzhitov,1 and Richard A. Flavell1,3
1Section of Immunobiology the serine/threonine kinase IRAK is recruited to the TLR
signaling complex via a DD-DD interaction (MedzhitovHoward Hughes Medical Institute
Yale University School of Medicine et al., 1998). IRAK is phosphorylated either by auto- or
crossphosphorylation (Cao et al., 1996; Wesche et al.,New Haven, Connecticut 06510
2 Section of Microbial Pathogenesis 1999), losing affinity for the TLR signaling complex. IRAK
is thus released from the complex, permitting bindingBoyer Center for Molecular Medicine
Yale University School of Medicine to downstream molecules such as TRAF6, causing acti-
vation of NF-B, JNK, p38, and ERK1/2 (Kawai et al.,New Haven, Connecticut 06536
1999; Medzhitov et al., 1998; Wesche et al., 1997; Zhang
et al., 1999). Like IRAK, IRAK-2 and IRAK-4 are ex-
pressed ubiquitously (Li et al., 2002; Muzio et al., 1997).Summary
However, IRAK-M is restricted to monocytes/macro-
phages (Wesche et al., 1999). IRAK-2 and IRAK-M haveToll-like receptors (TLRs) detect microorganisms and
protect multicellular organisms from infection. TLRs no kinase activity but activate NF-B when overex-
pressed in 293T cells and partially restore IL-1 signalingtransduce their signals through MyD88 and the serine/
threonine kinase IRAK. The IRAK family consists of two in IRAK/ cells (Muzio et al., 1997; Wesche et al., 1999).
All IRAKs act downstream of MyD88 and can bind toactive kinases, IRAK and IRAK-4, and two inactive ki-
nases, IRAK-2 and IRAK-M. IRAK-M expression is re- TRAF6 (Li et al., 2002; Medzhitov et al., 1998; Wesche
et al., 1997, 1999), suggesting that IRAK family proteinsstricted to monocytes/macrophages, whereas other IR-
AKs are ubiquitous. We show here that IRAK-M is play a redundant role. Indeed, IRAK and IRAK-4/ cells
and mice still partially respond to IL-1 and TLR stimula-induced upon TLR stimulation and negatively regu-
lates TLR signaling. IRAK-M prevented dissociation of tion (Kanakaraj et al., 1998; Suzuki et al., 2002; Swantek
et al., 2000; Thomas et al., 1999).IRAK and IRAK-4 from MyD88 and formation of IRAK-
TRAF6 complexes. IRAK-M/ cells exhibited increased Although the inflammatory response is critical to con-
trol the growth of pathogenic microorganisms (Cross etcytokine production upon TLR/IL-1 stimulation and
bacterial challenge, and IRAK-M/ mice showed in- al., 1995; Eden et al., 1988; Hagberg et al., 1984; Shahin
et al., 1987), excessive cytokine production is harmfulcreased inflammatory responses to bacterial infec-
tion. Endotoxin tolerance, a protection mechanism to the host and can even be fatal (Beutler et al., 1985;
Danner et al., 1991). Chronic repeated exposed to endo-against endotoxin shock, was significantly reduced in
IRAK-M/ cells. Thus, IRAK-M regulates TLR signal- toxin (or LPS) causes a transient increase in the thresh-
old to endotoxin challenge (Beeson, 1947; Greismaning and innate immune homeostasis.
et al., 1966; Ziegler-Heitbrock, 1995). This “endotoxin
tolerance” is a negative feedback mechanism to protectIntroduction
from endotoxic shock (Gustafson et al., 1995; Henricson
et al., 1990; Salkowski et al., 1998). Several factors areThe innate immune system is a host defense mechanism
that is conserved evolutionarily from plants to humans involved in this process, including TLR4 downregulation
(Nomura et al., 2000) and decreased NF-B activation(Medzhitov and Janeway, 1997). Essential components
of the innate immune system are Toll-like receptors (Goldring et al., 1998; Kastenbauer and Ziegler-Heit-
brock, 1999; Ziegler-Heitbrock et al., 1994). However,(TLRs), which recognize microbial products termed
PAMPs (pathogen-associated molecular patterns). the underlying mechanisms are largely unknown. To in-
vestigate the role of IRAK-M, we generated IRAK-M/PAMP recognition leads to activation of the innate im-
mune system, which in turn activates adaptive immunity mice using gene targeting. Surprisingly, innate immunity
was strongly enhanced in IRAK-M/ mice, and(Medzhitov and Janeway, 1997). TLRs recognize spe-
cific PAMPs through their LRR (leucine-rich repeat)-con- IRAK-M/ cells have strikingly impaired endotoxin tol-
erance, showing that IRAK-M negatively regulates TLRtaining extracellular domains: TLR2, TLR3, TLR4, TLR5,
TLR6, and TLR9 recognize peptidoglycan, double- signaling.
stranded RNA, LPS, Flagellin, mycoplasmal macro-
phage-activating lipopeptide-2 kDa (MALP-2), and CpG Results
bacterial DNA, respectively (Alexopoulou et al., 2001;
Hayashi et al., 2001; Hemmi et al., 2000; Hoshino et al., Molecular Cloning of irak-M and Generation
1999; Poltorak et al., 1998; Qureshi et al., 1999; Takeuchi of IRAK-M/ Mice
et al., 1999). Several different signaling components are A homology search for IRAK homologs in the EST data-
involved in TLR signaling. The adaptor molecule MyD88 bases and extension of the coding sequence by 5-
has dual binding domains, a TIR domain (Toll and IL-1- RACE resulted in the molecular cloning of the full-length
cDNA encoding a novel mouse kinase of 596 amino
acids and a calculated molecular mass of 68.7 kDa.3 Correspondence: richard.flavell@yale.edu
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BLAST search revealed that this kinase is the murine
ortholog of human IRAK-M, sharing 73% amino acid
sequence identity. Mouse IRAK-M has 12 serine/threo-
nine kinase subdomains and a conserved lysine in the
ATP binding site in subdomain II. However, like human,
mouse IRAK-M lacks the catalytically active aspartate in
subdomain VIB (see Supplemental Figure S1A at http://
www.cell.com/cgi/content/full/110/2/191/DC1), sug-
gesting that mouse IRAK-M lacks kinase activity. To
assess the role of IRAK-M, we generated IRAK-M/
mice. Homologous recombination was confirmed by
Southern blot analysis (see Supplemental Figures S1B
and S1C), and the absence of IRAK-M expression was
confirmed by Western blot using an antibody against
the C terminus of IRAK-M (see Supplemental Figure
S1D). To eliminate the possibility of functional truncated
protein containing the N terminus of IRAK-M, we per-
formed Northern blot analysis using a probe for the N
terminus of the irak-M gene. A smaller band of reduced
expression level was observed in heterozygous and ho-
mozygous cells (see Supplemental Figure S1E). The se-
quence of this transcript obtained by RT-PCR revealed
the transcribed gene to contain fused irak-M and neo
genes and an in-frame stop codon, predicting a mutant
product lacking a functional kinase domain (see Supple-
mental Figure S1F). Although we do not know if this
transcript is translated and stably expressed in cells,
an N-terminal IRAK-M fragment could be inhibitory for
signaling (Wesche et al., 1999). This molecule does not
appear to be functional in IRAK-M/ mice, however,
since heterozygous IRAK-M mice have no “inhibited”
Figure 1. Increased Cytokine Production of IRAK-M/ Macro-phenotype and since the phenotype of IRAK-M/ mice
phages upon PAMP Stimulationis increased (not decreased) inflammation. IRAK-M/
(A) IL-12 p40: Bone marrow-derived macrophage from wild-typemice were born at the expected Mendelian ratio and
and IRAK-M/ mice were plated in 24-well plates at a density of
showed no gross developmental abnormalities (data not 2  105 cells/well. Cells were stimulated with 10 M of CpG oligo
shown). DNA (CpG), 10 g/ml of mannan (MAN), 10 g/ml of zymosan (ZYM),
10 g/ml of double-stranded RNA (poly(IC)), 10 g/ml of peptidogly-
can (PGN), 1 or 10 ng/ml of LPS, 10 g/ml of Lipid A, 1 or 10 g/Enhanced Response in IRAK-M/ Macrophages
ml of lipoteichoic acid (LTA), or medium alone (MED). After 24 hr,upon TLR Stimulation
the concentration of IL-12 p40 in the supernatant was examined byTo characterize the effect of IRAK-M deficiency on TLR
ELISA. Experiments were repeated at least three times in triplicate
signaling, IRAK-M/ macrophages were prepared from with similar results. N.D. indicates not detected.
bone marrow and stimulated with various PAMPs. Sur- (B) TNF: Bone marrow-derived macrophages from wild-type and
prisingly, IRAK-M/ macrophages revealed signifi- IRAK-M/ mice were stimulated as in (A). After 24 hr, TNF in the
supernatant was determined by ELISA. Experiments were repeatedcantly increased production of IL-12 p40, IL-6, and TNF
at least three times in triplicate with similar results. N.D. indicateswhen compared to wild-type macrophages at 24 hr (Fig-
not detected.ures 1A–1C) and 6 hr after stimulation (not shown). IL-6
(C) IL-6: Bone marrow-derived macrophage from wild-type andproduction was greater in IRAK-M/ cells throughout
IRAK-M/ mice were stimulated as in (A). After 24 hr, IL-6 in the
the entire dose range of LPS (100 pg/ml to 1 mg/ml) supernatant was determined by ELISA. Experiments were repeated
(Figure 1D). Interestingly, although IRAK-M deficiency at least three times in triplicate with similar results. N.D. indicates
affected signaling by all TLRs tested, it had the strongest not detected.
(D) IL-6: Bone marrow-derived macrophage from wild-type andeffect on TLR9, which is a receptor for CpG DNA (Figures
IRAK-M/ mice were stimulated with LPS at the indicated concen-1A–1C).
tration. After 24 hr, the concentration of IL-6 in the supernatant wasSince IL-1 receptor (IL-1R) and TLR are members of
examined by ELISA. Experiments were repeated twice in triplicatean evolutionarily conserved receptor family and both
with similar results.
require MyD88 for signaling, we tested whether IRAK-M (E) Increased production of IL-6 by IRAK-M/ macrophages on
deficiency affects IL-1R signaling. Bone marrow-derived IL-1 stimulation. Bone marrow-derived macrophage were prepared
macrophages were stimulated with IL-1, and IL-6 pro- from wild-type and IRAK-M/ mice as (A) and stimulated with IL-1
as indicated for 24 hr (left) or with 100 ng/ml of IL-1 for indicatedduction was measured. The IL-1-induced production
times (right). IL-6 in the supernatant was determined by ELISA.of IL-6 in IRAK-M/ cells was higher in a time- and
Experiments were repeated twice in triplicate with similar results.dose-dependent manner (Figure 1E).
Increased Inflammatory Responses of IRAK-M/
tive bacteria, Salmonella typhimurium and EscherichiaMice Challenged with Bacteria In Vitro and In Vivo
coli, and assessed cytokine production in the cell super-To investigate the roles of IRAK-M in host defense, we
infected IRAK-M/ macrophages with two gram-nega- natants. Because wild-type S. typhimurium rapidly kills
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Figure 2. Increased Response of IRAK-M/ Mice upon Bacterial Challenge In Vitro
(A) IL-12 p40 to gram-negative bacterial challenge. Bone marrow-derived macrophages were prepared from wild-type and IRAK-M/ mice.
Cells were infected with Salmonella typhimurium (strains SB161 and S1230) or Escherichia coli (strain DH5) as described in Experimental
Procedures. After infection (24 hr), the concentration of IL-12 p40 in the supernatant was examined by ELISA. Abbreviations: HK, heat-killed
bacteria; N.D., not detected.
(B) IL-6 to gram-negative bacterial challenge. Wild-type and IRAK-M/ macrophages were prepared and infected with Salmonella typhimurium
(SB161 and SB1230) or Escherichia coli (DH5) as described in (A). After infection (24 hr), the concentration of IL-6 in the supernatant was
examined by ELISA. N.D. indicates not detected.
(C) TNF to gram-negative bacterial challenge. Wild-type and IRAK-M/macrophages were prepared and infected with Salmonella typhimurium
(S161 and S1230) or Escherichia coli (DH5) as described in (A). After infection (24 hr), the concentration of TNF in the supernatant was
examined by ELISA. N.D. indicates not detected.
(D) IL-12 p40 to gram-positive bacterial challenge. Bone marrow-derived macrophages from wild-type and IRAK-M/ mice were infected
with Listeria monocytogenes as described in Experimental Procedure. After infection (24 hr), IL-12 p40 in the supernatant was determined by
ELISA. Abbreviations: HK, heat-killed bacteria; N.D., not detected.
(E) IL-6 to gram-positive bacterial challenge. Wild-type and IRAK-M/ macrophages were infected with Listeria monocytogenes as described
in (D). After infection (24 hr), IL-6 in the supernatant was determined by ELISA. N.D. indicates not detected.
macrophages via the type III secretion system (Chen et macrophages produced increased IL-12p40 and IL-6,
upon treatment with either live or heat-killed L. monocy-al., 1996), we used two type III secretion-negative mu-
tant strains. IRAK-M/ macrophages challenged with togenes at 24 hr (Figures 2D and 2E) and 6 hr after
infection (data not shown).live or heat-killed S. typhimurium and E. coli produced
significantly increased amounts of IL-12p40, IL-6, and To investigate the role of IRAK-M in vivo, we infected
IRAK-M/ mice with a virulent strain of S. typhimurium.TNF at 24 hr (Figures 2A–2C) and 6 hr (data not shown)
after infection, compared to wild-type cells. IRAK-M/ We again chose a type III secretion mutant of S. typhimu-
rium that, although virulent in a mouse model of infection,macrophages were also challenged with the gram-posi-
tive bacterium Listeria monocytogenes, and cytokine gives significantly reduced intestinal pathology (Galan and
Curtiss, 1989; Penheiter et al., 1997). IRAK-M/ miceproduction was analyzed after infection. IRAK-M/
Cell
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Figure 3. Increased Response of IRAK-M/ Mice upon Salmonella typhimurium In Vivo
(A) No increased susceptibility to Salmonella infection in IRAK-M/ mice. Wild-type and IRAK-M/ mice were infected orally with Salmonella
typhimurium SB161 at 109 bacteria per mouse. After infection (72 hr), mice were euthanized, and colony-forming units (CFU) of Salmonella
typhimurium in spleen of wild-type and IRAK-M/ mice were determined (right). Eighteen mice in each group were used for the experiments.
The averages of S. typhimurium CFU in wild-type and IRAK-M/ mice are indicated with bars. The p values were determined by the Mann-
Whitney Test. Bacterial CFU of uninfected mice are also shown as control (n  3 for each group, left).
(B) Enlarged Peyer’s patch in small intestine of IRAK-M/ mice upon Salmonella challenge in vivo. Wild-type and IRAK-M/ mice were
infected orally with 109 Salmonella typhimurium SB161 CFU per mouse. After infection (72 hr), mice were euthanized and the small intestines
were examined. Typical appearance of the small intestine of wild-type and IRAK-M/ mice are presented.
(C) Increased number of enlarged Peyer’s patches in IRAK-M/ mice upon Salmonella challenge in vivo. Wild-type and IRAK-M/ mice were
infected with Salmonella typhimurium as described in (B). After infection (72 hr), mice were euthanized, and enlarged Peyer’s patches in the
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were infected with S. typhimurium orally and sacrificed volved in the induction of endotoxin tolerance. If so,
then IRAK-M might be expected to be inducible by TLR72 hr later to assess the intestinal inflammation and
splenic bacterial load. IRAK-M/ mice challenged signaling. To examine this, wild-type macrophages were
stimulated with LPS, and the levels of irak-M and irakwith S. typhimurium showed grossly enlarged Peyer’s
patches (Figure 3B). Further, the actual number of en- mRNA were assessed by Northern blotting. irak-M
mRNA was significantly induced by LPS stimulation,larged Peyer’s patches was significantly increased in
infected IRAK-M/ mice compared to wild-types (Fig- whereas irak mRNA was not induced (Figure 5A). The
protein levels of IRAK-M, IRAK, MyD88, and TRAF6 wereure 3C). Histological examination of Peyer’s patches in
IRAK-M/ mice infected with S. typhimurium revealed also examined by Western blotting. The expression of
IRAK-M was induced by LPS, whereas the expressionsevere inflammatory infiltrates in Peyer’s patches with
numerous polymorphonuclear cells (Figures 3I–3K) and of IRAK, MyD88, and TRAF6 were not (Figure 5B). We
next determined the ability of IRAK-M/ macrophagesaccompanying hemorrhage (Figures 3I and 3J), in signifi-
cant contrast to wild-type mice, which showed only mild to develop endotoxin tolerance. IRAK-M/ macro-
phages were first stimulated with 10 or 100 ng/ml ofPeyer’s patch inflammation (Figures 3E–3G). The bacte-
rial organ load was examined using spleens of infected LPS (primary LPS stimulation). After incubation for the
indicated periods, cells were restimulated with 10 ng/mice. In spite of the increased inflammatory response
in the gut, the number of bacterial colony-forming units ml of LPS (second LPS stimulation), and cytokine pro-
duction was examined after secondary LPS stimulation.(CFU) in spleens of infected IRAK-M/ mice were not
increased compared to wild-type mice (Figure 3A), sug- At each time point, cytokine levels were compared to
the cytokine levels of macrophages that received onlygesting that the increased inflammatory response in
IRAK-M/ mice was due to enhanced innate immunity the second LPS stimulation. As shown by previous stud-
ies (Nomura et al., 2000), wild-type macrophages showedrather than enhanced susceptibility to infection.
reduced cytokine production in accordance with a
longer incubation time and a higher dose of LPS (FigureEnhanced TLR Signaling in IRAK-M/ Cells
TLR stimulation activates NF-B, JNK, p38, and ERK1/2 5C), indicating that endotoxin tolerance is dependent
on the duration and dose of the primary LPS treatment.through the signaling molecules MyD88 and IRAK (Ka-
wai et al., 1999; Medzhitov et al., 1998). We therefore IRAK-M/ macrophages showed a lack of endotoxin
tolerance, and the cytokine levels produced upon LPSexamined the activation of these downstream effectors
of TLR signaling in IRAK-M/ cells. IRAK-M/ macro- restimulation were not decreased as much as in restimu-
lated wild-type macrophages (Figure 5C). IL-6 and TNFphages were stimulated with CpG DNA or LPS, and
the activation of NF-B, JNK, p38, and ERK1/2 was production after short incubation times was even in-
creased compared to that of nonpretreated macro-analyzed. CpG DNA stimulation of IRAK-M/ macro-
phages showed more rapid phosphorylation and degra- phages, indicating that IRAK-M is essential for endo-
toxin tolerance and that the absence of this negativedation of IB as compared to wild-type cells (Figure
4A). Phosphorylation of JNK, p38, and ERK1/2 was regulator causes abnormal enhancement of inflamma-
tory cytokine production. After 24 hr of incubation, how-faster and stronger in IRAK-M/ macrophages than in
wild-type cells (Figure 4A), indicating enhanced signal- ever, IRAK-M/ macrophages showed reduced IL-6
and TNF production and almost no IL-12p40 produc-ing in CpG DNA-stimulated IRAK-M/ macrophages
and suggesting that IRAK-M negatively regulates these tion, suggesting a possible second mechanism to medi-
ate endotoxin tolerance, which operates at later timesignaling pathways. LPS-stimulated IRAK-M/ macro-
phages also showed enhanced signaling to NF-B, JNK, points in IRAK-M/ cells.
p38, and ERK, although the augmentation was not as
great as for CpG (Figure 4B). To eliminate the possibility Inhibition of TLR Signaling by IRAK-M
IRAK and IRAK-4 are positive signal transducers,that IRAK-M/ cells are somehow primed and sensitive
to any stimuli, we stimulated IRAK-M/ macrophages whereas our data show IRAK-M to be a negative regula-
tor. IRAK activation leads to the phosphorylation of IRAKwith TNF. There was no increased NF-B, JNK, p38,
and ERK activation upon TNF stimulation, indicating and subsequent formation of IRAK and TRAF6 com-
plexes (Kojima et al., 1998). To test whether IRAK-Mthat the increased IRAK-M/ signaling is specific to
TLR stimulation (Figure 4C). inhibits the ligand-stimulated association of IRAK and
TRAF6, we transfected 293T cells with either control or
IRAK-M expression vectors. Cells were stimulated withIRAK-M Is Required for Endotoxin Tolerance
Our results showing that IRAK-M is a negative regulator IL-1, and the association of endogenous IRAK and
TRAF6 was examined. In mock-transfected cells, theof TLR signaling suggested that IRAK-M might be in-
small intestine of wild-type and IRAK-M/ mice were enumerated (right). Enlarged Peyer’s patches were readily apparent and up to 3 mm
in diameter. A total of ten mice in each group were used in the experiments. The p values were determined by the Student’s t test. The number
of enlarged Peyer’s patches in uninfected mice is also shown as control (n  7 for wild-type and n  6 for mutant mice, left). N.D. indicates
not detected.
(D–K) Increased inflammatory response in Peyer’s patches of IRAK-M/ mice upon Salmonella challenge. Wild-type and IRAK-M/ mice
were infected with Salmonella typhimurium as described in (B). After infection (72 hr), mice were euthanized, and Peyer’s patches were
removed, fixed with 10% formalin, and stained by hematoxylin and eosin (H&E). Three typical Peyer’s patches of wild-type mice (E, F, and
G) and IRAK-M/ mice (I, J, and K) after infection are presented. Typical Peyer’s patches of uninfected wild-type mice (D) and IRAK-M/
mice (H) are presented as controls. All figures are shown at the same magnification.
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Figure 4. Increased Signaling in IRAK-M/ Macrophages upon CpG Oligo DNA and LPS Stimulation
(A) Strongly increased signaling in IRAK-M/ macrophages upon CpG oligo DNA stimulation. Bone marrow-derived macrophages from wild-
type and IRAK-M/ mice were stimulated with 10 M of CpG oligo DNA for the indicated periods. Cell lysates were prepared and blotted with
anti-phospho-IB, anti-IB, anti-phospho-JNK, anti-JNK, anti-phospho-p38, anti-p38, anti-phospho-ERK1/2, and anti-ERK1/2 antibodies.
(B) Increased signaling in IRAK-M/ macrophages upon LPS stimulation. Bone marrow-derived macrophages were stimulated with 10 ng/
ml of LPS for the indicated times. Cell lysates were blotted with anti-phospho-IB, anti-IB, anti-phospho-JNK, anti-JNK, anti-phospho-
p38, anti-p38, anti-phospho-ERK1/2, and anti-ERK1/2 antibodies.
(C) No enhancement of signaling in IRAK-M/ macrophages upon TNF stimulation. Bone marrow-derived macrophages were stimulated
with 10 ng/ml of TNF for the indicated times. Cell lysates were blotted with anti-phospho-IB, anti-IB, anti-phospho-JNK, anti-JNK, anti-
phospho-p38, anti-p38, anti-phospho-ERK1/2, and anti-ERK1/2 antibodies.
IRAK/TRAF6 complex was induced 3 min after stimula- sion of IRAK-M did not affect association of IRAKKD and
MyD88. Thus, IRAK-M does not affect the association oftion and disappeared by 30 min, suggesting that an
IRAK/TRAF6 complex is formed transiently (Figure 6A, IRAK with TRAF6. Next, we tested whether IRAK-M
could inhibit recruitment of IRAK to the TLR signalingleft). In contrast to the sharp band of IRAK in the total
lysate, TRAF6-associated IRAK migrated diffusely, sug- complex. We cotransfected HA-tagged MyD88, Flag-
tagged IRAKKD, and Flag-tagged IRAK-M into 293Tgesting that activated phospho-IRAK was associated
with TRAF6. In transfected IRAK-M cells, the IRAK/ cells. After immunoprecipitation using an anti-HA anti-
body, MyD88-associated molecules were analyzed byTRAF6 complex was not induced (Figure 6A, right). We
next tested whether IRAK/TRAF6 complex formation by Western blotting with an anti-Flag antibody. Cotransfec-
tion of MyD88 and IRAK resulted in the association ofTLR stimulation is also inhibited by IRAK-M expression.
We transfected TLR2-expressing 293T cells with either these two molecules (Figure 6D, left). Surprisingly, co-
transfection of IRAK-M together with MyD88 and IRAKempty vector or IRAK-M expression vectors. Cells were
stimulated with peptidoglycan, and the association of resulted in enhanced, not decreased, association of
IRAK with MyD88, suggesting that IRAK-M does notIRAK and TRAF6s was examined. Again, IRAK/TRAF6
association was observed in mock-transfected cells but inhibit the recruitment of IRAK to MyD88. Further, we
tested whether phosphorylated IRAK associates withnot in IRAK-M-transfected cells (Figure 6B).
These results suggested two ways to explain MyD88. Wild-type IRAK and MyD88 were cotransfected,
and their association was examined. Transfection of wild-IRAK-M’s inhibitory role. First, IRAK-M might inhibit
the association of IRAK and TRAF6 directly. Second, type IRAK and MyD88 resulted in readily detectable
slowly migrating bands and only a low level of the fasterIRAK-M could affect the activation of IRAK by TLR/IL-1R
stimulation. To test the first possibility, we cotransfected migrating band, suggesting that most IRAK was phos-
phorylated under these conditions. (Figure 6D, right gel,293T cells with HA-tagged TRAF6 and FLAG-tagged
IRAK together with IRAK-M expression vectors. Lysates first lane). Coimmunoprecipitation studies showed that
phosphorylated IRAK did not associate with MyD88were prepared and immunoprecipitated by anti-HA anti-
body, and the association of IRAK and TRAF6 was ex- (Figure 6C, top). In contrast, cotransfection of IRAK-M
together with MyD88 and wild-type IRAK resulted inamined. Overexpression of wild-type IRAK causes the
appearance of slowly migrating bands that reflect IRAK increased relative levels of the faster migrating (unphos-
phorylated) band (Figure 6C, middle), suggesting thatautophosphorylation (Cao et al., 1996; Wesche et al.,
1999; Yamin and Miller, 1997). Coexpression of IRAK IRAK-M inhibits IRAK phosphorylation. These immuno-
precipitation studies also detected an enhanced associ-and TRAF6 caused their association, and IRAK-M ex-
pression did not inhibit this association (Figure 6C, left). ation of IRAK and MyD88. Notably, even phosphorylated
IRAK, which has little affinity for MyD88, also remainedWe also tested the association of TRAF6 and kinase
inactive IRAK (IRAKKD, K206A mutant). Again, expres- associated with MyD88 in the presence of IRAK-M, indi-
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cating that IRAK-M increases the affinity of both phos-
phorylated and unphosphorylated forms of IRAK for
MyD88. These data suggest that IRAK-M does not inhibit
the recruitment of IRAK to the TLR signaling complex,
but rather that IRAK-M inhibits the dissociation of IRAK
from TLR signaling complex after IRAK activation.
IRAK-4 is the newest member of the IRAK protein
family; it acts as a signal transducer upon TLR and IL-1
stimulation downstream of MyD88 (Li et al., 2002; Suzuki
et al., 2002). We tested whether IRAK-M also inhibits
the release of IRAK-4 from MyD88. The vectors express-
ing HA-tagged MyD88, V5-tagged IRAK-4, and FLAG-
tagged IRAK-M were transfected into 293T cells, and
the association of MyD88 and IRAK-4 was examined.
Like IRAK, the overexpression of IRAK-4 led to its auto-
phosphorylation, and this phosphorylated form failed to
associate stably with MyD88 (Figure 6E, first and third
lanes; Li et al., 2002). IRAK-M coexpression caused not
only the association of IRAK-M with MyD88 but also the
induced association of IRAK-4 with MyD88 (Figure 6E,
second and fourth lanes), suggesting that IRAK-M may
inhibit dissociation of IRAK-4 from MyD88.
Discussion
Innate immunity is a first line of defense against patho-
genic microorganisms (Medzhitov and Janeway, 1997).
The innate immune system stimulated via TLRs acti-
vates the adaptive immune system by the production
of proinflammatory cytokines such as IL-1, IL-6, TNF,
or IL-12 and the induction of key surface molecules,
which drive T cell activation, including MHC, CD40,
CD80, and CD86 (Akira et al., 2001; Medzhitov and Jane-
way, 1997; Schnare et al., 2001). Cytokines, however,
induce pronounced positive feedback in the immune
system, which, if left unchecked, can cause severe im-
munopathology. Indeed, a number of pathologies such
as Crohn’s and inflammatory bowel disease are postu-Figure 5. IRAK-M Expression Is Induced by Endotoxin and Is Re-
lated to result from disregulated innate immunity (Vanquired for Endotoxin Tolerance
Heel et al., 2001). However, the mechanisms by which(A) Induction of irak-M mRNA in macrophages after LPS stimulation.
innate immunity is held in check are largely unknown.Bone marrow-derived macrophages were stimulated with 10 ng/ml
of LPS for the indicated times. The level of irak-M, irak, and HPRT We show here that the kinase IRAK-M exerts this
mRNA were determined by Northern blot analysis using total RNA critical negative regulatory role. Consistent with this
and irak-, irak-M-, and HPRT-specific 32P-labeled DNA probes. Hy- function, macrophages from IRAK-M/ mice showed
poxanthine phosphoribosyltransferase (HRPT) was used as control. enhanced proinflammatory cytokine production when
(B) Induction of the expression of IRAK-M in macrophages after
infected with either live or dead bacteria (Figures 2A–2E).LPS stimulation. Bone marrow-derived macrophages were stimu-
Further, IRAK-M/ mice had greatly exacerbated intes-lated with 10 ng/ml of LPS for the indicated times. The levels of
IRAK-M, IRAK, MyD88, and TRAF6 were examined in cell lysates tinal inflammatory responses to challenge with the en-
by Western blot analysis using anti-IRAK-M, anti-IRAK, anti-MyD88, teric pathogenic bacteria Salmonella typhimurium (Fig-
and anti-TRAF6 antibodies. ures 3D–3K). Compared to wild-type mice, infected
(C) Perturbed endotoxin tolerance in IRAK-M/ macrophages. En- IRAK-M/ mice exhibited enlarged and inflamed Pey-
dotoxin tolerance was induced in bone marrow-derived macro-
er’s patches, the site of Salmonella colonization of thephages from wild-type or IRAK-M/ mice by preactivation with 10
intestinal tract. The exacerbated response of IRAK-M/or 100 ng/ml of LPS (1st LPS). After the indicated incubation period,
cells were washed and restimulated with 10 ng/ml of LPS (2nd LPS). mice is likely the result of enhanced TLR signaling. Con-
After 24 hr, IL-6, IL-12 p40, and TNF was determined by ELISA. sistent with this, IRAK-M/ macrophages stimulated
The concentrations of cytokines in each sample were normalized to with known TLR agonists such as LPS or CpG DNA
the concentration of the sample that received the second stimulation displayed increased NF-B and MAP kinase activation
alone, and values are represented as percentages of the cytokine
(Figures 4A and 4B), both well-characterized outputs oflevels in samples receiving second stimulation alone. White bar
TLR stimulation (Kawai et al., 1999; Medzhitov et al.,indicates wild-type macrophages; black bar indicates IRAK-M/
macrophages. 1998; Zhang et al., 1999).
Persistent stimulation with LPS results in endotoxin
tolerance, where responses are dampened by hitherto
poorly understood negative regulatory mechanisms. We
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Figure 6. A Molecular Mechanism of Inhibition of TLR Signaling by IRAK-M
(A) Inhibition of IRAK/TRAF6 complex formation on IL-1 stimulation by IRAK-M overexpression. 293T cells were transfected with either
pcDNA3 or pcDNA3-IRAK-M vectors. After 24 hr, cells were stimulated with 10 ng/ml of IL-1 for the indicated periods. Lysates were
immunoprecipitated with an anti-TRAF6 antibody, and the association with IRAK and TRAF6 was examined by Western blotting with an anti-
IRAK antibody. The expression levels of IRAK, TRAF6, and IRAK-M in cell lysates was examined by Western blotting using anti-IRAK, anti-
TRAF6, and anti-FLAG antibodies, respectively.
(B) Inhibition of IRAK/TRAF6 complex formation on PGN stimulation by IRAK-M overexpression. TLR2-transfected 293T cells (FLAG-TLR2/
CD14/293T cells) were transfected with either pcDNA3 or pcDNA3-IRAK-M expression vectors. After 24 hr, cells were stimulated with 10 g/
ml of PGN for the indicated periods. Lysates were prepared and immunoprecipitated with anti-TRAF6 antibody, and association with IRAK
and TRAF6 was examined by Western blotting and anti-IRAK antibody. The expression levels of IRAK, TRAF6, and IRAK-M in cell lysates
were examined by Western blotting using anti-IRAK, anti-TRAF6, and anti-FLAG antibodies, respectively.
(C) IRAK-M does not inhibit the association of IRAK (left) or IRAKKD (right) to TRAF6. HA-tagged TRAF6, Flag-tagged IRAK, or IRAKKD
expression vectors with or without Flag-tagged IRAK-M expression vectors were cotransfected into 293T cells. Lysates were prepared and
immunoprecipitated with anti-HA antibody, and the association between TRAF6 and IRAK (left) or between TRAF6 and IRAKKD (right) were
examined by Western blotting with an anti-Flag antibody. The expression levels of IRAK, IRAKKD, and IRAK-M, or MyD88 in lysates were
examined by Western blotting using anti-FLAG or anti-HA antibodies, respectively.
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show that IRAK-M is a key component of this important
control system. Thus, IRAK-M/ macrophages were
significantly impaired in the development of toler-
ance upon repeated stimulation with LPS (Figure 5C).
IRAK-M/ macrophages, however, retained some ca-
pacity to develop LPS tolerance at late time points, sug-
gesting the existence of additional regulatory mecha-
nisms to control the response to LPS. The recently
reported downregulation of TLR4 may be one such
mechanism (Nomura et al., 2000).
How does IRAK-M exert its function? A notable feature
of IRAK-M is that it lacks kinase activity (Wesche et
al., 1999) and has a weak capacity to be phosphorylated
(Wesche et al., 1999). It is therefore likely that these fea-
tures are important for its negative regulatory role. How-
ever, the role of the kinase activity of IRAK in TLR signal-
ing is controversial. Indeed, kinase-inactive mutants of
IRAK, as well as kinase-inactive IRAK-M and IRAK-2,
can still activate NF-B when overexpressed in cultured
cells (Knop and Martin, 1999; Maschera et al., 1999;
Muzio et al., 1997; Wesche et al., 1999). Further, overex-
pression of kinase-deficient IRAK mutants can restore Figure 7. Model for the Regulation of TLR Signaling by IRAK-M
NF-B activation in IRAK/ cells upon IL-1 stimulation (A) Activation of IRAK/IRAK-4 upon TLR stimulation in the absence
(Knop and Martin, 1999; Li et al., 1999). We show that of IRAK-M. PAMP stimulation of TLR induces multimerization of
these receptors, which in turn causes recruitment of MyD88 andkinase-inactive IRAK-M exerts a negative regulatory role
IRAK to TLRs (1). Proximity of IRAK/IRAK-4 causes auto- or cross-in TLR/IL-1R signaling, suggesting autophosphorylation
phosphorylation (2). The phosphorylation of IRAK/IRAK-4 thenas important for signaling by this kinase family. Indeed,
causes a conformational change (3). The conformational change ofa kinase-inactive mutant of IRAK-4 has a dominant-
IRAK/IRAK-4 results in reduced affinity for the TLR signaling com-
negative effect on IL-1R signaling (Li et al., 2002). plex, and IRAK/IRAK-4 are released to make possible the activation
We propose the following model for IRAK-M function. of downstream molecules. For simplicity, other adaptor molecules
in TLRs, such as Tollip (Burns et al., 2000) and Tirap/Mal (FitzgeraldActivation of TLRs by PAMPs dimerizes these receptors,
et al., 2001; Horng et al., 2001), are not included in the figure.following which IRAK, IRAK-4, and the adaptor protein
(B) Inhibition of TLR signaling by IRAK-M. In the presence of IRAK-M,MyD88 are recruited, resulting in IRAK and IRAK-4 acti-
TLR stimulation by PAMPs results in the recruitment of not onlyvation and their subsequent phosphorylation (Figure
IRAK/IRAK-4 but also IRAK-M to the signaling complex. This associ-
7A). Phosphorylation of IRAK or IRAK-4 results in a con- ation inhibits the release of IRAK/IRAK-4 from the TLR signaling
formational change, causing loss of affinity for the TLR complex by either inhibiting the phosphorylation of IRAK/IRAK-4 or
stabilizing the TLR/MyD88/IRAK(-4) complex, resulting in the inter-signaling complex and allowing the stimulation of down-
ruption of downstream signaling.stream signaling through association with signaling mol-
ecules such as TRAF6. IRAK-M inhibits this process by
inhibiting dissociation of IRAK and IRAK-4 from the TLR
signaling complex by either inhibiting the phosphoryla- ent in the TLR signaling complex or, alternatively, may be
an artifact created by overexpression of these inactivetion of IRAK and IRAK-4 or stabilizing the TLR/MyD88/
IRAK(-4) complex (Figure 7B). This inhibitory mechanism kinases.
Like IRAK-M, IRAK-2 may also function as a negativehas greater effect after cells are exposed to LPS be-
cause IRAK-M levels are increased when cells are stimu- regulator of TLR/IL-1R signaling. Indeed, both proteins
lack kinase activity (see Supplemental Figure S1A atlated with LPS; in this way, IRAK-M induces LPS toler-
ance (Figure 5). Despite their lack of kinase activity, http://www.cell.com/cgi/content/full/110/2/191/DC1;
Muzio et al., 1997; Wesche et al., 1999) and increaseIRAK-M and IRAK-2 are able to complement NF-B acti-
vation in IRAK/ cells to some degree, albeit less effec- expression upon stimulation (Figure 5A; Wesche et al.,
1999). However, these related proteins are expressedtively than wild-type IRAK (Wesche et al., 1999). We
propose that this may occur upon their phosphorylation differently; while IRAK-M is preferentially expressed in
monocytes/macrophages cells, IRAK-2 is ubiquitousby another kinase(s), such as IRAK-4, that may be pres-
(D) Expression of IRAK-M increases the association of MyD88 with IRAKKD (left) and IRAK (right). HA-tagged MyD88, Flag-tagged IRAKKD,
or IRAK expression vectors with or without Flag-tagged IRAK-M expression vectors were cotransfected into 293T cells. Lysates were prepared
and immunoprecipitated with anti-HA antibody, and the association of MyD88 with IRAKKD (left), or IRAK (right) was examined by Western
blotting using an anti-Flag antibody. The expression levels of IRAKKD, IRAK, and IRAK-M or of MyD88 in lysates was examined by Western
blotting using anti-FLAG or anti-HA antibodies, respectively.
(E) Expression of IRAK-M induces the association of MyD88 with IRAK-4. HA-tagged MyD88 and V5-tagged IRAK-4 expression vectors with
or without Flag-tagged IRAK-M expression vectors were cotransfected into 293T cells. Lysates were prepared and immunoprecipitated with
anti-HA antibody, and the association of MyD88 with IRAK-4 or IRAK-M was examined by Western blotting with anti-V5 or anti-FLAG antibodies.
The expression levels of IRAK-4, IRAK-M, or MyD88 in lysates were examined by Western blotting using anti-V5, anti-FLAG, or anti-HA
antibodies, respectively.
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cultured in 10 ml at an initial density of 4  105 cells/ml in 100 mm(Muzio et al., 1997; Wesche et al., 1999). Because TLR
petri dish (Becton Dickinson) at 37	C in humidified 10% CO2 for 5expression is high in myeloid lineage cells and IL-1 re-
days. At day 3, 5 ml of medium was added. Cells were harvestedceptors are ubiquitous (McMahan et al., 1991; Muzio et
with cold DPBS (Invitrogen), washed, resuspended in DMEM supple-
al., 2000), IRAK-M may be the main regulator of TLR mented with 10% FBS, and used at a density of 2  105 /ml for
signaling, whereas IRAK-2 is a regulator of IL-1R signal- experiments unless mentioned otherwise. Cells were left untreated
for at least 4 hr at 37	C in 10% CO2 prior to further handling.ing. Studies using IRAK-2/ mice should elucidate the
role of IRAK-2.
Listeria Infection of MacrophagesWe have identified IRAK-M as a negative regulator of
The cells were cultured without antibiotics, and L. monocytogenesTLR signaling. IRAK-M is induced by TLR stimulation
(ATCC strain 43251) was added at an MOI of 50 bacteria per macro-
and required for endotoxin tolerance, indicating that phage. After incubation for 30 min, extracellular bacteria were re-
IRAK-M is a key component of a feedback regulatory moved by washing the cells three times with DPBS. To prevent
system of innate immunity. IRAK-M therefore plays a reinfection, the cells were cultured in medium containing gentamicin
sulfate (50 g/ml, Invitrogen).critical role in the maintenance of homeostasis of the
innate immune system.
Salmonella typhimurium and E. coli Infection
of Macrophages In VitroExperimental Procedures
The S. typhimurium strain SB161, which carries a nonpolar mutation
in the invG gene, has been previously described (Kaniga et al.,Molecular Cloning and Expression Vectors
1994). In vitro infection of macrophages with S. typhimurium wasFull-length mouse IRAK-M cDNA was obtained by an EST clone
performed as described (Chen et al., 1996). Briefly, macrophages(GenBank accession number AA930623) and 5-RACE (rapid amplifi-
were seeded without antibiotics in 24-well dishes at 2  105 cells/cation of cDNA ends) using mouse cDNA of LPS-activated macro-
well. Eighteen hours later, macrophages were infected with SB161phages and primer 5-cct ata tga gca acg gga cgc tt. Mammalian
or the E. coli strain DH5- at an MOI of 50 bacteria per macrophageexpression vectors encoding NH2-terminal Flag-tagged mouse
at 37	C in DMEM 
 10% FBS. After 25 min, macrophages wereIRAK and IRAKKD were a kind gift of Sankar Ghosh (Yale). A con-
washed 3 times with HBSS, and 100 g/ml gentamicin was addedstruct encoding Flag-tagged human IRAK-M was a kind gift of Zao-
to kill any extracellular bacteria. Culture media was collected at 6dan Cao, Tularik, Inc. (Wesche et al., 1999). Human IRAK-4 cDNA
and 24 hr postinfection for cytokine measurements.was obtained by RT-PCR using human liver cDNA (CLONTECH) and
primers 5-cac cat gaa caa acc cat aac acc atc aac and 5-aga agc
Salmonella Challenge of Mice In Vivotgt cat ctc ttg cag cag, cloned into a pcDNA3.1 expression vector
Age- and sex-matched groups of mice were infected orally with(Invitrogen) and verified by sequencing.
Salmonella typhimurium strain SB161 at 109 bacteria per mouse.
Mice were euthanized 72 hr after infection. Enlarged Peyer’s patchesGeneration of IRAK-M/ Mice
were fixed with 10% formalin and stained by Hematoxylin and eosinA 129SV/J genomic library (Stratagene) was screened with the mu-
(H&E). Each spleen mouse was homogenized in 10 ml of BSG buffer,rine irak-M cDNA to obtain six phage-carrying overlapping genomic
and serial dilutions of the homogenate were plated on LB/Strepclones encompassing irak-M. The targeting vector replaced a 1.2
agar plates and incubated at 37	C for 18 hr, and colony-formingkb genomic fragment containing three exons encoding two-thirds
units (CFU) were counted.of the kinase domain with the loxP-flanked neomycin resistance
(neo) gene expression cassette. The targeting vector was linearized
Cytokine Production from Macrophageswith Not I and electroporated into W9.5 ES cells. Clones resistant
Bone marrow-derived macrophages were cultured with LPS, Lipidto G418 and gancyclovir were selected, and homologous recombi-
A, LTA, PGN, Mannan, Zymosan, poly(I-C), CpG DNA, or medianation was confirmed by Southern blotting. Eight out of 70 clones
alone as indicated for 6 and 24 hr. Macrophages were infected withscreened were positive for homologous recombination. Three tar-
Salmonella typhimurium or Listeria monocytogenes and culturedgeted clones were injected into C57BL/6 blastocysts and transferred
for 6 and 24 hr. IL-12 p40, IL-6, and TNF-were measured by ELISA.into pseudopregnant foster mothers, and the resulting male chimeric
mice were bred to C57BL/6 females to obtain 
/ mice. Germline
Northern Blot Analysistransmission was verified for all three ES clones by Southern blot
Total RNA was isolated using TRIzol reagent (Invitrogen) accordinganalysis of tail DNA from F1 offspring. Interbreeding of 
/ mice
to the manufacturer’s instruction. Total RNA (20 g) was then sepa-was performed to generate / IRAK-M mice. The phenotypes of
rated by electrophoresis, blotted onto nitrocellulose (Amersham),all three lines were identical.
and probed with 32P-labeled DNA probes. The irak-, irak-M-, and
HPRT-specific probes were generated by PCR using forward primerReagents
5-gccagtggaaagtgatgagagtg and reverse primer 5-gaaaaagcctLipopolysacchride (LPS) from Salmonella abortus equi, Lipid A from
gatgacagcagttg for murine irak, forward primer 5-tccttcaggtgtccttEscherichia coli, lipoteichoic acid (LTA) from Staphylococcus
ctccactg and reverse primer 5-cctcttctccattggcttgctc for murineaureus, Mannan from Saccharomyces cerevisiae, and Zymosan A
irak-M, and forward primer 5-gttggatacaggccagactttgttg and re-from Saccharomyces cerevisiae were from Sigma. Peptidoglycan
verse primer 5-gagggtaggctggcctataggct for HPRT.(PGN) from Staphylococcus aureus was from Fluka. Poly (I-C) was
from Amersham Pharmacia Biotech. Phosphorothioate-modified
Western Blot Analysis and ImmunoprecipitationCpG oligo DNA (tccatgacgttcctgacgtt) was synthesized in the HHMI
Cell lysis, immunoprecipitation, and blotting were as described (Ko-Biopolymer & W.M. Keck Biotechnology Resource Laboratory in
bayashi et al., 1999). The membrane was blotted with an antibodyYale University. Recombinant human IL-1 and murine TNF were
to phosphorylated-IB, IB, phosphorylated-JNK, JNK, phos-purchased from R&D. The anti-Flag M2 monoclonal antibody, anti-
phorylated-p38, p38, phosphorylated-ERK1/2, ERK1/2 (Cell Signal-HA antibody, and rabbit anti-IRAK-M antibody were from Sigma,
ing), IRAK-1 (Santa Cruz and Upstate), TRAF6 (Santa Cruz), MyD88BabCO, and Chemicon International, respectively.
(StressGen), IRAK-M (Chemicon International), FLAG-tag (Sigma),
HA-tag (BabCO), and V5-tag (Invitrogen).Bone Marrow-Derived Macrophages
Bone marrow-derived macrophages were prepared as described
(Celada et al., 1984). Briefly, bone marrow from tibia and femur Acknowledgments
was obtained by flushing with DMEM (Invitrogen). The medium was
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